Liminatus Pharma Inc. Cla... (LIMN)
NASDAQ: LIMN
· Real-Time Price · USD
3.96
-0.04 (-1.00%)
At close: Aug 18, 2025, 3:59 PM
4.01
1.15%
Pre-market: Aug 19, 2025, 04:00 AM EDT
Liminatus Pharma Class A Common Stock Revenue
Liminatus Pharma Class A Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Liminatus Pharma Class A Common Stock generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
3
Market Cap
107.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | n/a |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |